Eckelman Living Trust Dated February 5, 2014, 10% Owner, Chief Scientific Officer at Inhibrx, Inc. (INBX), sold 40,000 shares at $24.20 ($968K) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Open-market sale of $968k INBX by 10% Owner, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.20 | 39,600 | $958K | 99.0% |
| 2 | $24.71 | 400 | $10K | 1.0% |
| Total | $24.21 avg | 40,000 | $968K | 100% |
| Filing → |
| INBX | SELL | 2021-02-18 | $440K | — | Filing → |